Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyDrHank vs Nolu

By GLP-1 ScorecardUpdated

Our take

I’d use Nolu’s four-week quote as a starting point if you want to know when the next bill is due. MyDrHank publishes different prices on its landing and injection pages, so ask for the selected price and refill schedule before choosing a longer term.

MyDrHank for an itemized quote

The MyDrHank review shows which advertised figures differ. Ask which price applies to the prescribed preparation and what you would owe for the next shipment.

Read the MyDrHank review →

Compare the same formulation and usable supply, with both debit schedules in writing.

MyDrHank
Site position #105

Lower score

NoluFactor scores not reassessed.
Site position #131

Higher score

Score comparison

Nolu has the higher recorded score — 69.7/100 to 68.2/100, but only just.

Nolu grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nolu advertises four-week prices that include the consultation, medication and shipping. MyDrHank is close behind and may still be the better fit — see the factor split below.

Before you choose

Before comparing the headline prices, the MyDrHank review and the Nolu review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, MyDrHank vs Strut Health and Nolu vs RX Bella compare each of them with another graded program, and the list of alternatives to MyDrHank ranks the programs closest to MyDrHank on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueMyDrHank +5
70
65
Dose & formulationMyDrHank +4
84
80
Clinical oversightMyDrHank +1
66
65
Labs & monitoringNolu +10
50
60
FulfillmentNolu +7
78
85
Contract termsNolu +17
48
65
MyDrHank · top barNolu · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMyDrHankNolu
WeighScore68.2/10069.7/100
GradeCC
Site position#105#131
SemaglutideFrom $171/mo oral or injectable on GLP-1 lander; injection product page from $178/mo (conflicting offer terms; confirm)$199 per 4 weeks injectable, $239 per 4 weeks oral (compounded)
TirzepatideFrom $200/mo on GLP-1 lander; product page from $240/mo (conflicting offer terms; confirm)$279 per 4 weeks (compounded)
CoverageConfirm prescription and state; contiguous-U.S. shipping claim does not establish individual eligibilityAdvertises all 50 states and Washington, D.C.; availability varies by service
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
MyDrHank

Site position #105 · C

Strengths

  • Public landing and product pages show starting prices before medical intake
  • Compounded injection options and a separate oral semaglutide menu are advertised, with formulation differences to discuss with the prescriber
  • Product pages advertise consultation, delivery, check-ins and unlimited clinical messaging; response times were not tested
  • Terms identify the platform operator and offer the current pharmacy-partner list on request

What to consider

  • The GLP-1 lander shows $171/$200 injectable starting rates, while separate injection pages show $178/$240; applicable purchase terms remain unresolved
  • Published base plan fields do not establish that a particular promotion is unavailable or what an individual will actually pay
  • The reviewed GLP-1 terms did not establish the cancellation cutoff, unused-prepayment refund formula or declined-treatment financial outcome
  • The assigned medical practice, prescriber and dispensing location remain unestablished; no current individual license verification is claimed
  • Dose, concentration, usable supply, laboratory costs and state-specific availability require confirmation
  • Compounded preparations are not FDA-approved; displayed branded-product trial results do not establish outcomes for these formulations
Nolu

Site position #131 · C

Factor scores not reassessed.

Strengths

  • Advertised prices include consultation, medication and shipping
  • Oral semaglutide is listed alongside injectable options
  • Dashboard cancellation is available

What to consider

  • Four-week billing produces more frequent charges than calendar-month billing
  • Cancellation must reach Nolu at least 72 hours before the next bill
  • The public cards do not establish the full charge for each longer plan

Featured provider

MyDrHank

MyDrHank scores 68.2/100 (C). MyDrHank advertises compounded tablets and injections, but its GLP-1 landing page and separate product pages show different starting prices; get one written offer before choosing a term.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard